ArticleJournal of robotic surgery2019
Nationwide outcomes and costs of laparoscopic and robotic vs. open hepatectomy.
Article in Journal of robotic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 7 syntheses or guidelines pooled it, 48 citations in OpenAlex.
- Economic impact of robotic liver resection: systematic review of costs, resource utilization, and hospital stay.Surgical endoscopy · 2026Pooled it
- Pooled it
- Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis.World journal of surgical oncology · 2024Pooled it
- A meta-analysis between robotic hepatectomy and conventional open hepatectomy.Journal of robotic surgery · 2024Pooled it
- Economic analysis of open versus laparoscopic versus robotic hepatectomy: a systematic review and meta-analysis.The European journal of health economics : HEPAC : health economics in prevention and care · 2021Pooled it
- Comparative clinical outcomes of robot-assisted liver resection versus laparoscopic liver resection: A meta-analysis.PloS one · 2020Pooled it
- Simultaneous Robot Assisted Colon and Liver Resection for Metastatic Colon Cancer.JSLS : Journal of the Society of Laparoendoscopic SurgeonsPooled it
- Article
- Evolution of Robotic-Assisted Hepatobiliary Surgery.Bioengineering (Basel, Switzerland) · 2025Review
- Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis.Hepatobiliary surgery and nutrition · 2024Article
- Surgical technique for fully robotic two-stage hepatectomy using indocyanine green fluorescence imaging for bilobar colorectal liver metastases.Journal of visualized surgery · 2024Article
- Robotic Versus Laparoscopic Hepatectomy: A Single Surgeon Experience of 629 Consecutive Minimally Invasive Liver Resections.World journal of surgery · 2023Article
- International experts consensus guidelines on robotic liver resection in 2023.World journal of gastroenterology · 2023Review
- Robotic major and minor hepatectomy: critical appraisal of learning curve and its impact on outcomes.Surgical endoscopy · 2023Article
- Total robotic right hepatectomy for multifocal hepatocellular carcinoma using vessel sealer.Annals of hepato-biliary-pancreatic surgery · 2023Article
- Cost analysis of robotic versus open hepatectomy: Is the robotic platform more expensive?Journal of robotic surgery · 2022Article
- Data resources for evaluating the economic and financial consequences of surgical care in the United States.The journal of trauma and acute care surgery · 2022Review
- Comprehensive analysis of laparoscopic, robotic, and open hepatectomy outcomes using the nationwide readmissions database.Journal of robotic surgery · 2022Article
- Review on Perioperative and Oncological Outcomes of Robotic Gastrectomy for Cancer.Journal of personalized medicine · 2021Review
- Robotic gastrointestinal surgery: learning curve, educational programs and outcomes.Updates in surgery · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The safety of hepatectomy continues to improve and it holds a key role in the management of benign and malignant hepatic lesions. Laparoscopic and robotic approaches to hepatectomy are increasingly utilized. The purpose of this study was to compare outcomes and costs of laparoscopic and robotic vs. open approaches to hepatectomy and to determine the national nonelective postoperative readmission rate, including readmission to other hospitals. The Nationwide Readmission Database from 2013 to 2014 was queried for all patients undergoing hepatectomy. Patients undergoing laparoscopic and robotic hepatectomies were compared to patients undergoing open hepatectomy. Multivariate logistic regression was implemented to determine the odds ratios (OR) for non-elective readmission within 45 days. There were 10,870 patients who underwent hepatectomy from 2013 to 2014 and 724 (6.7%) were approached with laparoscopic or robotic technique. The robotic cohort had lower mean cost of the index admission ($24,983 ± $18,329 vs. open $32,391 ± $31,983, p < 0.001, 95% CI - 18,292 to 534), shorter LOS (4.5 ± 3.8 vs. lap 6.8 ± 6.0 vs. open 7.6 ± 7.7 days, p < 0.01), and were less likely to be readmitted within 45 days (7.9% vs. 13.0% lap vs. 13.8% open, p = 0.05). The robotic cohort was slightly younger (mean age 57.5 ± 13.5 vs. lap 60.1 ± 13.8 vs. open 58.9 ± 13.7, p < 0.05), and no significant differences were seen by Charlson Comorbidity Index. Anastomosis of hepatic duct to GI tract carried higher odds of mortality (OR 2.87, p < 0.01) and higher odds of readmission (OR 1.40, p < 0.01). LOS above 7 days increased odds of readmission (OR 2.24, p < 0.01). Nearly one-fifth of patients readmitted after hepatectomy present to a different hospital. Robotic hepatectomy was associated with favorable cost and readmission outcomes compared to laparoscopic and open hepatectomy patients, despite similar patient comorbid burdens and patient's age. Length of stay over 7 days and anastomosis of hepatic duct to GI tract are strong risk factors for readmission and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.